Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NUMIF is expected to report earnings to fall 50.00% to 0 cents per share on November 29
Q3'24
Est.
$-0.01
Q2'24
Est.
$-0.01
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.01
Q3'23
Missed
by $0.01
The last earnings report on July 11 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 13.41K shares outstanding, the current market capitalization sits at 44.18M.